The FLOW study highlights the risks of CKD progression, cardiovascular disease and death in those with type 2 diabetes and CKD, and the significant benefits of the pillars of treatment: ACE inhibitors/ARBs, SGLT2 inhibitors, finerenone and, now, semaglutide
Consumer Behavior Trends and Sectoral Impacts The impact of GLP-1RAs on the life sciences sector and the broader healthcare sector is clear
Knowing when to contact healthcare services is essential for patients taking GLP-1 receptor agonists, as timely intervention can prevent serious complications and ensure appropriate management of potential gallbladder disease
Can BPC 157 Repair a Torn Tendon
GLP-1 medications work through several mechanisms
4,24 In clinical trials thus far, GLP-1 agonists have shown their weight-loss effects only in conjunction with diet and exercise